Rheumatoid arthritis Trials in Kitchener, Canada
Conditions / Rheumatoid arthritis / Kitchener, Canada
Clinical trials for Rheumatoid arthritis investigate a range of treatment strategies and patient populations.
26 total trials for this combination
Showing top 10 of 26 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01194414 | A Study to Compare Subcutaneous Versus Intravenous Administration of RoActemra/Actemra (Tocilizumab) in Participants With Moderate to Severe Active Rheumatoid Arthritis | COMPLETED | PHASE3 |
| NCT01885078 | An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis | COMPLETED | PHASE3 |
| NCT00720798 | An Extension Study of Tocilizumab (Myeloma Receptor Antibody [MRA]) in Patients Completing Treatment in Tocilizumab Core Studies | COMPLETED | PHASE3 |
| NCT01721057 | A Study in Moderate to Severe Rheumatoid Arthritis Participants | COMPLETED | PHASE3 |
| NCT00476996 | A Study of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Who Don't Have a Response to Anti-TNF-α Therapy (SCRIPT) | TERMINATED | PHASE3 |
| NCT00106522 | A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy | COMPLETED | PHASE3 |
| NCT01710358 | A Study in Moderate to Severe Rheumatoid Arthritis | COMPLETED | PHASE3 |
| NCT01331837 | A Study of Tocilizumab in Comparison to Etanercept in Participants With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors | COMPLETED | PHASE4 |
| NCT00717236 | Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis | COMPLETED | PHASE3 |
| NCT01007435 | A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis | COMPLETED | PHASE3 |